These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis. Steffan J, Parks C, Seewald W, North American Veterinary Dermatology Cyclosporine Study Group. J Am Vet Med Assoc; 2005 Jun 01; 226(11):1855-63. PubMed ID: 15934253 [Abstract] [Full Text] [Related]
4. Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis. Nuttall TJ, McEwan NA, Bensignor E, Cornegliani L, Löwenstein C, Rème CA. Vet Dermatol; 2012 Feb 01; 23(1):4-10, e1-2. PubMed ID: 21718368 [Abstract] [Full Text] [Related]
5. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs. Little PR, King VL, Davis KR, Cosgrove SB, Stegemann MR. Vet Dermatol; 2015 Feb 01; 26(1):23-30, e7-8. PubMed ID: 25496303 [Abstract] [Full Text] [Related]
6. A double-blinded, randomized, controlled, crossover evaluation of a zinc methionine supplement as an adjunctive treatment for canine atopic dermatitis. McFadden RA, Heinrich NA, Haarstad AC, Tomlinson DJ. Vet Dermatol; 2017 Dec 01; 28(6):569-e138. PubMed ID: 28736909 [Abstract] [Full Text] [Related]
7. Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs. Olivry T, Steffan J, Fisch RD, Prélaud P, Guaguère E, Fontaine J, Carlotti DN, European Veterinary Dermatology Cyclosporine Group. J Am Vet Med Assoc; 2002 Aug 01; 221(3):370-7. PubMed ID: 12164533 [Abstract] [Full Text] [Related]
8. A placebo-controlled, double-blind study evaluating the effect of orally administered polyunsaturated fatty acids on the oclacitinib dose for atopic dogs. Schäfer L, Thom N. Vet Dermatol; 2024 Aug 01; 35(4):408-417. PubMed ID: 38465482 [Abstract] [Full Text] [Related]
9. The effect of a spot-on formulation containing polyunsaturated fatty acids and essential oils on dogs with atopic dermatitis. Blaskovic M, Rosenkrantz W, Neuber A, Sauter-Louis C, Mueller RS. Vet J; 2014 Jan 01; 199(1):39-43. PubMed ID: 24355814 [Abstract] [Full Text] [Related]
10. Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega. Litzlbauer P, Weber K, Mueller RS. Cytokine; 2014 Mar 01; 66(1):54-9. PubMed ID: 24548425 [Abstract] [Full Text] [Related]
11. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial. Olivry T, Rivierre C, Jackson HA, Murphy KM, Davidson G, Sousa CA. Vet Dermatol; 2002 Apr 01; 13(2):77-87. PubMed ID: 11972891 [Abstract] [Full Text] [Related]
12. The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study. Carlotti DN, Boulet M, Ducret J, Machicote G, Jasmin P, Rème CA, Albouy M. Vet Dermatol; 2009 Oct 01; 20(5-6):405-11. PubMed ID: 20178477 [Abstract] [Full Text] [Related]
13. A randomized, controlled study to evaluate the steroid sparing effect of essential fatty acid supplementation in the treatment of canine atopic dermatitis. Saevik BK, Bergvall K, Holm BR, Saijonmaa-Koulumies LE, Hedhammar A, Larsen S, Kristensen F. Vet Dermatol; 2004 Jun 01; 15(3):137-45. PubMed ID: 15214949 [Abstract] [Full Text] [Related]
14. A randomized, double-blind, placebo-controlled study to evaluate the effect of EFF1001, an Actinidia arguta (hardy kiwi) preparation, on CADESI score and pruritus in dogs with mild to moderate atopic dermatitis. Marsella R, Messinger L, Zabel S, Rosychuck R, Griffin C, Cronin PO, Belofsky G, Lindemann J, Stull D. Vet Dermatol; 2010 Feb 01; 21(1):50-7. PubMed ID: 19843302 [Abstract] [Full Text] [Related]
15. Efficacy of dimetinden and hydroxyzine/chlorpheniramine in atopic dogs: a randomised, controlled, double-blinded trial. Eichenseer M, Johansen C, Mueller RS. Vet Rec; 2013 Nov 02; 173(17):423. PubMed ID: 24114734 [Abstract] [Full Text] [Related]
16. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis. Michels GM, Ramsey DS, Walsh KF, Martinon OM, Mahabir SP, Hoevers JD, Walters RR, Dunham SA. Vet Dermatol; 2016 Dec 02; 27(6):478-e129. PubMed ID: 27647569 [Abstract] [Full Text] [Related]
17. Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis. Dip R, Carmichael J, Letellier I, Strehlau G, Roberts E, Bensignor E, Rosenkrantz W. BMC Vet Res; 2013 Sep 03; 9():173. PubMed ID: 24004561 [Abstract] [Full Text] [Related]
18. The influence of topical unsaturated fatty acids and essential oils on normal and atopic dogs. Tretter S, Mueller RS. J Am Anim Hosp Assoc; 2011 Sep 03; 47(4):236-40. PubMed ID: 21673338 [Abstract] [Full Text] [Related]
19. The glucocorticoid sparing efficacy of Phytopica in the management of canine atopic dermatitis. Schmidt V, McEwan N, Volk A, Helps J, Morrell K, Nuttall T. Vet Dermatol; 2010 Feb 03; 21(1):96-105. PubMed ID: 20187915 [Abstract] [Full Text] [Related]
20. Management of canine atopic dermatitis using the plant extract PYM00217: a randomized, double-blind, placebo-controlled clinical study. Ferguson EA, Littlewood JD, Carlotti DN, Grover R, Nuttall T. Vet Dermatol; 2006 Aug 03; 17(4):236-43. PubMed ID: 16827666 [Abstract] [Full Text] [Related] Page: [Next] [New Search]